Related Experiment Video

Updated: Jul 19, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology
03:59

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

Melatonin in cancer management: progress and promise

Brittney Jung1, Nihal Ahmad

  • 1Department of Dermatology, University of Wisconsin, Madison, WI 53706, USA.

Cancer Research
|October 19, 2006
PubMed

Insights

Melatonin, a pineal hormone, demonstrates cancer-preventive and tumor-inhibiting effects in various models. It may also enhance chemotherapy efficacy and reduce side effects, showing promise as a future cancer prevention agent.

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • The pineal hormone melatonin exhibits significant chemopreventive, oncostatic, and tumor inhibitory properties.
  • Melatonin's biological effects are proposed to operate through multiple proposed mechanisms.
  • Melatonin may play a role in cancer development and progression, warranting further investigation.

Purpose of the Study:

  • To critically evaluate the progress in understanding melatonin's role in preventing and reversing cancer development.
  • To explore the potential of melatonin as an adjuvant therapy to enhance chemotherapy efficacy and mitigate side effects.
  • To discuss future prospects for the development of melatonin as a chemopreventive agent.

Main Methods:

  • Review of in vitro and in vivo experimental models investigating melatonin's effects on neoplasia.
  • Analysis of proposed mechanisms underlying melatonin's biological actions in cancer.
  • Critical evaluation of existing research on melatonin's chemopreventive and therapeutic potential.

Main Results:

  • Melatonin demonstrates chemopreventive, oncostatic, and tumor inhibitory effects across various experimental cancer models.
  • Evidence suggests melatonin can independently influence cancer development and progression.
  • Melatonin shows potential in adjuvant settings to improve chemotherapy outcomes by increasing efficacy and reducing toxicity.

Conclusions:

  • Melatonin possesses significant potential as a chemopreventive agent and an adjunct in cancer therapy.
  • Further research into melatonin's mechanisms and clinical applications is warranted.
  • Melatonin may offer a promising strategy for cancer prevention and treatment enhancement.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...